Subject
Dermatology,Histology,Pathology and Forensic Medicine
Reference20 articles.
1. Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis con agentes biológicos, 2013. I. Consideraciones de eficacia y selección del tratamiento;Actas Dermosifiliogr,2013
2. A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis;Mrowietz;J Eur Acad Dermatol Venereol,2013
3. Off-label biologic regimens in psoriasis: A systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapy;Brezinski;PLoS One,2012
4. Efficacy, safety, and medication cost implications of adalimumab 40 mg weekly dosing in psoriasis patients with sub-optimal response to 40 mg every other week dosing: Results from an open-label study;Leonardi;Br J Dermatol,2012
5. Recommendations for the long-term treatment of psoriasis with infliximab: A dermatology expert group consensus;Reich;Dermatology,2008